title: Interactions between N-acetylcysteine and ascorbic acid in modulating mutagenesis and carcinogenesis.
abstract: Both ascorbic acid (AsA, vitamin C) and N-acetylcysteine (NAC), a precursor and analogue of glutathione, possess a broad array of biological properties underlying their protective role in a variety of pathophysiological conditions. However, under certain circumstances, AsA behaves as a pro-oxidant rather than an anti-oxidant and produces adverse effects. This prompted us to evaluate whether NAC could interact with AsA in preventing mutation and cancer. AsA significantly increased spontaneous revertants in the Salmonella typhimurium strains TA102 and TA104, which are sensitive to oxidative mutagens. In contrast, NAC lowered the spontaneous background in TA104 and neutralized the negative effects of AsA. Moreover, NAC and AsA showed additive effects in reducing chromium(VI) and in reverting its mutagenicity. A single i.p. injection of urethane (1 g/kg body weight) to 120 A/J mice resulted, after 4 months, in the formation of a total of 1,532 lung tumors, 425 in the 30 mice treated with the carcinogen only, 404 in those treated with urethane plus AsA, 365 in those treated with urethane plus NAC and 338 in those treated with urethane plus the combination of AsA and NAC (both given daily with drinking water at the dose of 1 g/kg body weight). Compared to positive controls, tumor multiplicity was poorly affected by AsA, whereas it was significantly decreased by NAC and even more so by its combination with AsA. The overall volumes of lung tumors in the 4 groups were 107.5, 89.3, 61.3 and 49.7 mm(3), respectively. Tumor sizes were slightly but significantly decreased in mice treated with AsA and more so in those treated with NAC and NAC plus AsA, their combination being significantly more effective than each individually. All protective effects elicited by combining the 2 drugs were additive. Therefore, NAC prevents the adverse effects of AsA on spontaneous mutagenicity; at the same time, this thiol behaves in an additive fashion with AsA, inhibiting the mutagenicity of chromium(VI) and the lung tumorigenicity of urethane in mice. These findings suggest that NAC and AsA could conveniently be combined in cancer chemoprevention and other pharmacological interventions.
authors.affiliation: Department of Health Sciences, University of Genoa, Genoa, Italy.
authors.forename: F
authors.initials: F
authors.lastname: D'Agostini
authors.forename: R M
authors.initials: RM
authors.lastname: Balansky
authors.forename: A
authors.initials: A
authors.lastname: Camoirano
authors.forename: S
authors.initials: S
authors.lastname: de Flora
mesh_terms: D000111:Acetylcysteine / Q000378:metabolism*; D000818:Animals; D001205:Ascorbic Acid / Q000378:metabolism*; D015197:Carcinogenicity Tests; D002471:Cell Transformation, Neoplastic / Q000378:metabolism*; D002857:Chromium / Q000378:metabolism; D004355:Drug Stability; D005260:Female; D008175:Lung Neoplasms / Q000139:chemically induced / Q000378:metabolism*; D051379:Mice; D016296:Mutagenesis / Q000502:physiology*; D014520:Urethane
chemical_list: D002857:Chromium; D014520:Urethane; D001205:Ascorbic Acid; D000111:Acetylcysteine